How to appeal a Humana immune globulin (ivig/scig) for pidd denial

The framework that applies to your appeal

Medicare Advantage plans follow a separate appeal track from commercial plans. Reconsideration must be requested within 60 days; if the plan misses its deadline, the case auto-forwards to the IRE (Maximus).

Humana-specific note: Heavily Medicare Advantage focused. MA-specific appeal track (42 CFR Part 422 Subpart M) applies — 60 days to request reconsideration, NOT the 180 days for commercial plans. Auto-forward to IRE (Maximus) if Humana misses deadline.

What Humana's policy requires for immune globulin (ivig/scig) for pidd

Cited policy: Humana Medical Coverage Policy — Immune Globulins (IVIG/SCIG/fSCIG) for Primary and Selected Secondary Immunodeficiency

PIDD per AAAAI/ACAAI + IDF criteria. Secondary hypogammaglobulinemia (post-rituximab, CLL, MM, post-HSCT) covered when IgG <400 mg/dL + recurrent serious bacterial infections + impaired vaccine response (Bonilla 2015; AAAAI 2017 Eight Principles). Dose 300-800 mg/kg q3-4 wk targeting trough.

How Humana denies immune globulin (ivig/scig) for pidd — and how to counter it

Where Humana pushes back: 1) Try FFP first; 2) Secondary hypogamma not covered; 3) Sinusitis not severe enough; 4) Try prophylactic antibiotics first.

Counter-arguments that hold up: FFP is NOT acceptable substitute for chronic immune reconstitution per Bonilla 2015 + IDF — variable IgG content, no standardized functional antibody, transfusion risks (TRALI). For secondary hypogamma: AAAAI 2017 Eight Principles + CMS NCD 250.3 cover symptomatic acquired antibody deficiency with documented infections + vaccine-response failure. IDF 10 Warning Signs (>=4 ear infections/yr, >=2 serious sinus/yr, >=2 pneumonias/yr) + Bonilla 2015 SS support immune reconstitution when recurrent sinopulmonary infections coexist with humoral defect. Antibiotic prophylaxis is adjunctive, not substitute — Bonilla 2015 explicit. Document breakthroughs on prophylaxis if applicable.

What Humana typically denies for immune globulin (ivig/scig) for pidd

Across Humana's commercial and Medicare books, denials cluster around a small number of patterns. For immune globulin (ivig/scig) for pidd, expect:

• MA plan step therapy on Part B drugs
• Skilled nursing facility days
• Prior auth on specialty drugs
• OON emergency reduction

Treatments most often denied in this category

These are the immune globulin (ivig/scig) for pidd treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Privigen (IVIG)
• Gamunex-C (IVIG)
• Octagam (IVIG)
• Gammagard Liquid (IVIG)
• Flebogamma DIF (IVIG)
• Bivigam (IVIG)

How to submit the appeal to Humana

1. Read the denial letter — note the exact denial reason code and the appeal deadline (60 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Humana cited in the denial.
3. File the appeal through Humana's portal (members: https://www.humana.com ; providers: https://www.humana.com/provider). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In KY, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Humana's prior-authorization criteria by drug: Humana PA criteria on ApprovalHelp.